Cannabidiol, or CBD, is one of more than five hundred and forty (540) chemical compounds discovered in marijuana. Although CBD oil can be derived from any cannabis plant, most OTC CBD products use hemp oil. Hemp refers to any variety of cannabis with a THC content of less than 0.3%.
CBD hemp-derived products are legal in all 50 states as of December 2018. However, their distribution and use are still limited in a few jurisdictions. The Food and Drug Administration classifies CBD as a food additive. Despite being available over the counter, its quality and purity are unchecked.
What Do The Studies Reveal?
More information about CBD’s therapeutic potential and its mechanism of action is needed. Recent studies have shown that CBD may be beneficial for the following conditions:
Preliminary studies suggest cannabidiol (CBD) may aid sleep in insomnia patients.
· Addiction Disorders
Studies have shown CBD lessens the desire to consume alcoholic beverages, opiate painkillers, and stimulants. Opioid withdrawal symptoms may also be alleviated.
CBD significantly impacts inflammation, suggesting it may be therapeutic for illnesses like rheumatoid arthritis.
· Chronic Pain
Chronic pain is another potential area of benefit for seya relief. It may aid with sleep and overall quality of life for those with chronic pain and alleviate their discomfort. However, there is conflicting data about discomfort. Therefore further long-term study is required.
· Nerve Pain
A tiny study found that using topical CBD reduced nerve discomfort. Additionally, preliminary research suggests that oral CBD may aid in preventing nerve pain associated with some forms of chemotherapy. Further studies on the effects of CBD on nerve pain are still being conducted.
According to the available research, CBD has shown promise in alleviating pain and social anxieties. There was also some evidence from a tiny trial that CBD, in the right amounts, could aid with performance anxiety. However, Most of these studies are relatively small and don’t consider the long-term consequences. Therefore, we require additional data.
Initial research on CBD’s antidepressant potential is promising. It seems to affect serotonin levels in the brain in a similar way that antidepressant drugs do.
Psychotic CBD alone (without THC) may help reduce psychotic symptoms, according to preliminary clinical research. In addition, it had fewer adverse effects than competing antipsychotics. Long-term safety data, however, is lacking.
Seizures from certain types of epilepsy, which don’t react well to other drugs, can be effectively treated with CBD.
Research on CBD’s potential in treating various additional medical issues is now underway. However, it is not yet known whether or if CBD is beneficial in treating these disorders.
Some forms of childhood epilepsy may respond to CBD oil, as it has received FDA approval. It’s also commonly accessible over-the-counter (OTC) in various doses. CBD has shown promise in treating anxiety, pain, and insomnia. Depression and substance abuse may also benefit from this.